Dr. Reddy's Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RDY and other ETFs, options, and stocks.

About RDY

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. 

CEO
Erez Israeli
CEOErez Israeli
Employees
27,527
Employees27,527
Headquarters
Hyderabad, Telangana
HeadquartersHyderabad, Telangana
Founded
1984
Founded1984
Employees
27,527
Employees27,527

RDY Key Statistics

Market cap
11.02B
Market cap11.02B
Price-Earnings ratio
29.63
Price-Earnings ratio29.63
Dividend yield
0.49%
Dividend yield0.49%
Average volume
2.78M
Average volume2.78M
High today
$13.29
High today$13.29
Low today
$12.90
Low today$12.90
Open price
$13.14
Open price$13.14
Volume
2.04M
Volume2.04M
52 Week high
$15.67
52 Week high$15.67
52 Week low
$11.36
52 Week low$11.36

RDY News

TipRanks 2d
Dr. Reddy’s Wins DCGI Nod for Zytorvi in Advanced Esophageal Cancer, Expanding Its Oncology Reach

Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ) has provided an update. Dr. Reddy’s has received approval from India’s Central Drugs Standard Control Organisati...

MarketWatch 3d
Dr. Reddy's Laboratories advances Monday, outperforms competitors - MarketWatch

...

Dr. Reddy's Laboratories advances Monday, outperforms competitors - MarketWatch

Analyst ratings

45%

of 40 ratings
Buy
45%
Hold
22.5%
Sell
32.5%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.